Here we have provided evidence that meloxicam executes its antitumor effects against HCC by regulating the COX-2/ matrix metalloproteinase (MMP)-2/E-cadherin, AKT, apoptotic and autophagic pathways via both COX-2-dependent and -independent ways. The gene discussed is PTGS2; the disease is hepatocellular carcinoma.